Utilization has been self-limiting, you might say
35 Notably, this protective effect appears to be dependent on the duration of treatment, with only a GLP-1RA treatment period exceeding 52 weeks being associated with decreased fracture risk
As a result, many healthcare providers now prescribe these drugs as part of a comprehensive treatment plan for obesity, particularly for patients with comorbidities such as type 2 diabetes, heart disease, and hypertension
Similarly, another recent study with tirzepatide shows that if someone loses 10% or 15% of their body weight by six months, theyre more likely to keep it off after one year. While ongoing research will continue to shed light on how fast GLP-1s work, Dr
Huizhou
Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat